OPK (STOCKS)
Opko Health Inc.
$1.380000
-0.040000 (-2.82%)
Prev close: $1.420000
Company Information
- Exchange
- XNAS
- Sector
- Health Services
- Industry
- Medical/Nursing Services
- CEO
- Phillip Frost
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,060.90M
- Employees
- 2,997
- P/E (TTM)
- -5.11
- P/B (TTM)
- 0.89
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
5
Buy
4
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.07 | $-0.07 | +0.0007 | +0.99% |
|
Dec 2025 (Q4)
|
$-0.04 | $-0.07 | +0.0293 | +42.28% |
|
Sep 2025 (Q3)
|
$0.03 | $-0.05 | +0.0755 | +165.93% |
|
Jun 2025 (Q2)
|
$-0.19 | $-0.11 | -0.0755 | -65.94% |
Financial Statements
| Revenues | $581.12M |
| Benefits Costs and Expenses | $185.15M |
| Cost Of Revenue | $372.05M |
| Costs And Expenses | $682.38M |
| Gross Profit | $209.08M |
| Nonoperating Income/Loss | -$127.69M |
| Operating Expenses | $603.94M |
| Selling, General, and Administrative Expenses | $212.52M |
| Research and Development | $122.39M |
| Operating Income/Loss | -$101.26M |
| Income/Loss Before Equity Method Investments | -$228.95M |
| Income/Loss From Continuing Operations After Tax | -$212.91M |
| Income/Loss From Continuing Operations Before Tax | -$33.59M |
| Income/Loss From Equity Method Investments | -$22.00K |
| Income Tax Expense/Benefit | -$16.05M |
| Income Tax Expense/Benefit, Deferred | -$15.47M |
| Net Income/Loss | -$212.92M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$212.92M |
| Net Income/Loss Available To Common Stockholders, Basic | -$212.92M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.27 |
| Diluted Earnings Per Share | -$0.27 |
| Basic Average Shares | 2,329,034,971 |
| Diluted Average Shares | 2,331,799,422 |
| Assets | $1.86B |
| Current Assets | $535.36M |
| Inventory | $64.40M |
| Other Current Assets | $470.97M |
| Noncurrent Assets | $1.32B |
| Fixed Assets | $72.59M |
| Intangible Assets | $496.35M |
| Other Non-current Assets | $752.50M |
| Liabilities | $652.19M |
| Current Liabilities | $148.38M |
| Accounts Payable | $44.18M |
| Other Current Liabilities | $104.21M |
| Noncurrent Liabilities | $503.80M |
| Long-term Debt | $345.68M |
| Other Non-current Liabilities | $158.13M |
| Equity | $1.20B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $1.20B |
| Liabilities And Equity | $1.86B |
| Net Cash Flow From Operating Activities | -$163.30M |
| Net Cash Flow From Operating Activities, Continuing | -$163.30M |
| Net Cash Flow From Investing Activities | $187.97M |
| Net Cash Flow From Investing Activities, Continuing | $187.97M |
| Net Cash Flow From Financing Activities | -$119.19M |
| Net Cash Flow From Financing Activities, Continuing | -$119.19M |
| Net Cash Flow | -$94.52M |
| Net Cash Flow, Continuing | -$94.52M |
| Comprehensive Income/Loss | -$219.38M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$199.85M |
| Other Comprehensive Income/Loss | -$61.32M |
| Other Comprehensive Income/Loss Attributable To Parent | $17.52M |